Advertisement

Rating Scales for Depression

  • Cristina CusinEmail author
  • Huaiyu Yang
  • Albert Yeung
  • Maurizio Fava
Chapter
Part of the Current Clinical Psychiatry book series (CCPSY)

Abstract

Over the past few decades, a number of clinician-rated and patient-rated instruments have been developed as primary efficacy measures in depression clinical trials. All those scales have relative strengths and weaknesses and some of them have been more successful than others, and have become the gold standards for depression clinical research. With all these measures available and with the evidence of their variable performance in clinical trials, it is becoming increasingly important to select primary efficacy measures that are reliable, valid, and that fit well within the aims of depression clinical trials. This article will review the main considerations that investigators need to make when choosing a primary efficacy measure for major depressive disorder (MDD). There is a clear need for a thorough discussion of the methodological issues concerning the use of these scales, as suggested also by Demyttenaere and De Fruyt in a recent review [1], because clinical trials researchers in depression continue to struggle with the ability to detect signals of the efficacy of antidepressant agents.

Keywords

Depression Rating scales Questionnaires Assessment Mood Psychiatry 

Notes

Acknowledgments

This work has been funded in whole or in part with Federal funds from the National Institute of Mental Health, National Institutes of Health, under Contract N01MH90003 (STAR*D) and GMO N01MH90003 (NIMH Depression Trials Network). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

The authors thank Dr Janet B.W. Williams, Dr Kenneth Kobak, and Dr John Rush for their contributions to this chapter.

References

  1. 1.
    Demyttenaere K, De Fruyt J: Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 2003; 72:61–70CrossRefPubMedGoogle Scholar
  2. 2.
    Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Williams JBW: Research assessments: to standardize or not to standardize?, in Research Designs and Methods in Psychiatry. Edited by Fava M, Rosenbaum JF, Amsterdam, Elsevier, 1992, pp 31–36Google Scholar
  4. 4.
    Williams JB: A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry 1988; 45:742–7CrossRefPubMedGoogle Scholar
  5. 5.
    Bech P: Measurement issues., in Textbook of biological psychiatry. Part 1: Basic principles. Edited by D’Haenen H. New York, Wiley, 2002Google Scholar
  6. 6.
    Bech P, Tanghoj P, Andersen HF, Overo K: Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology (Berl) 2002; 163:20–5CrossRefGoogle Scholar
  7. 7.
    Hamilton M: Hamilton rating scale for Depression (Ham-D), in Handbook of psychiatric measures. Washington DC, APA, 2000, pp 526–8Google Scholar
  8. 8.
    Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54:573–83CrossRefPubMedGoogle Scholar
  9. 9.
    Bagby RM, Ryder AG, Schuller DR, Marshall MB: The Hamilton depression rating scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161:2163–77CrossRefPubMedGoogle Scholar
  10. 10.
    Moberg PJ, Lazarus LW, Mesholam RI, Bilker W, Chuy IL, Neyman I, Markvart V: Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 2001; 9:35–40CrossRefPubMedGoogle Scholar
  11. 11.
    Muller MJ, Dragicevic A: Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices. J Affective Dis 2003; 77:65–9CrossRefGoogle Scholar
  12. 12.
    Kobak KA, Lipsitz JD, Feiger A: Development of a standardized training program for the Hamilton Depression Scale using internet-based technologies: results from a pilot study. J Psychiatric Res 2003; 37:509–15CrossRefGoogle Scholar
  13. 13.
    Takahashi N, Tomita K, Higuchi T, Inada T: The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA). Hum Psychopharmacol 2004; 19:187–92CrossRefPubMedGoogle Scholar
  14. 14.
    Davidson J, Turnbull CD, Strickland R, Miller R, Graves K: The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatrica Scandinavica 1986; 73:544–8CrossRefPubMedGoogle Scholar
  15. 15.
    Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851–5CrossRefPubMedGoogle Scholar
  16. 16.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561–71CrossRefPubMedGoogle Scholar
  17. 17.
    Beck AT, Steer RA: Manual for the Beck Depression Inventory. San Antonio, TX, 1993Google Scholar
  18. 18.
    Beck AT, Steer RA, Brown GK: Manual for the Beck Depression Inventory, 2nd ed. San Antonio, TX, 1996Google Scholar
  19. 19.
    Beck AT, Steer RA, Ball R, Ranieri W: Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67:588–97CrossRefPubMedGoogle Scholar
  20. 20.
    Steer RA, Clark DA, Beck AT, Ranieri WF: Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther 1999; 37:183–90CrossRefPubMedGoogle Scholar
  21. 21.
    Biggs JT, Wylie LT, Ziegler VE: Validity of the Zung Self-rating Depression Scale. Br J Psychiatry 1978; 132:381–5CrossRefPubMedGoogle Scholar
  22. 22.
    Beck AT, Steer RA, Carbin M: Psychometric properties of the Beck depression inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988; 8:77–100CrossRefGoogle Scholar
  23. 23.
    Vazquez C, Sanz J: Fiabilidad y validez factorial de la versión española del inventario de depresión de Beck., in III Congreso de Evaluación Psicológica. Barcelona, 1991Google Scholar
  24. 24.
    Richter P, Werner J, Heerlein A, Kraus A, Sauer H: On the validity of the Beck depression inventory. A review. Psychopathology 1998; 31:160–8CrossRefPubMedGoogle Scholar
  25. 25.
    Zung WWK: Zung Self-rating Depression Scale (Zung SDS), in Handbook of psychiatric measures. Washington, DC, APA, 2000, pp 534–537Google Scholar
  26. 26.
    Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382–9CrossRefPubMedGoogle Scholar
  27. 27.
    Lobo A, Chamorro L, Luque A, Dal-Re R, Badia X, Baro E: Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc) 2002; 118:493–9CrossRefGoogle Scholar
  28. 28.
    Fleck MP, Guelfi JD, Poirier-Littre MF, Loo H: Application of a structured interview guide adapted to 4 depression scales. Encephale 1994; 20:479–86PubMedGoogle Scholar
  29. 29.
    Williams JB: Structured Interview Guide for the Montgomery Asberg Depression Rating Scale (SIG-MA). Biometrics Research Department, 1996Google Scholar
  30. 30.
    Fava M: Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry 2002; 63:305–7CrossRefPubMedGoogle Scholar
  31. 31.
    Galinowski A, Lehert P: Structural validity of MADRS during antidepressant treatment. Int Clin Psychopharmacol 1995; 10:157–61CrossRefPubMedGoogle Scholar
  32. 32.
    Schmidtke A, Fleckenstein P, Moises W, Beckmann H: Untersuchungen zur Reliabilitat und Validitat einer deutschen Version der Montgomery-Asberg Depression-Rating Scale (MADRS). Schweizer Archiv fur Neurologie und Psychiatrie 1988; 139:51–65PubMedGoogle Scholar
  33. 33.
    Muller MJ, Himmerich H, Kienzle B, Szegedi A: Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS). J Affective Dis 2003; 77:255–60CrossRefGoogle Scholar
  34. 34.
    Montgomery SA, Asberg M: Mongomery-Asberg depression rating scale, in Handbook of psychiatric measures. Washington, DC, APA, 2000, pp 531–33Google Scholar
  35. 35.
    Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65–87CrossRefPubMedGoogle Scholar
  36. 36.
    Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH: The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med 1996; 26:477–86CrossRefPubMedGoogle Scholar
  37. 37.
    Rush AJ, Hiser W, Giles DE: A comparison of self-reported versus clinician-related symptoms in depression. J Clin Psychiatry 1987; 48:246–8PubMedGoogle Scholar
  38. 38.
    Corruble E, Legrand JM, Duret C, Charles G, Guelfi JD: IDS-C and IDS-sr: psychometric properties in depressed in-patients. J Affect Dis 1999; 56:95–101CrossRefPubMedGoogle Scholar
  39. 39.
    Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34:73–82CrossRefPubMedGoogle Scholar
  40. 40.
    Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB: Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology 2005; 30:405–16CrossRefPubMedGoogle Scholar
  41. 41.
    Zung WW: A self-rating depression scale. Arch Gen Psychiatry 1965; 12:63–70CrossRefPubMedGoogle Scholar
  42. 42.
    White J, White K, Razani J: Effects of endogenicity and severity on consistency of standard depression rating scales. J Clin Psychiatry 1984; 45:260–1PubMedGoogle Scholar
  43. 43.
    Kellner R: The development of sensitive scales for research in therapeutics, in Research designs and methods in Psychiatry., vol 9. Edited by Fava M, Rosenbaum JF. Amsterdam, The Netherlands, Elsevier, 1992, pp 213–222Google Scholar
  44. 44.
    Moran P, Lambert MJ: Measurement methods in affective disorders: consistency with DSM-III diagnosis., in The Assessment of Psychotherapy Outcome. Edited by Lambert MJ, DeJulio SS, Christensen ER. New York, Wiley- Interscience, 1983, pp 263–303Google Scholar
  45. 45.
    Maier W, Philipp M: Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Rating Scale. Pharmacopsychiatry 1985; 18Google Scholar
  46. 46.
    Moller HJ: Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 2001; 251 Suppl 2:II13–20CrossRefPubMedGoogle Scholar
  47. 47.
    Williams JB: Standardizing the Hamilton depression rating scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci 2001; 251 Suppl 2:II6–12CrossRefPubMedGoogle Scholar
  48. 48.
    Bailey J, Coppen A: A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression. Br J Psychiatry 1976; 128:486–9CrossRefPubMedGoogle Scholar
  49. 49.
    Domken M, Scott J, Kelly P: What factors predict discrepancies between self and observer ratings of depression? J Affective Dis 1994; 31:253–9CrossRefGoogle Scholar
  50. 50.
    Prusoff BA, Klerman GL, Paykel ES: Concordance between clinical assessments and patients’ self-report in depression. Archives of General Psychiatry 1972; 26:546–52CrossRefPubMedGoogle Scholar
  51. 51.
    Berrios GE, Chen EY: Recognising psychiatric symptoms. Relevance to the diagnostic process. Br J Psychiatry 1993; 163:308–14CrossRefPubMedGoogle Scholar
  52. 52.
    Enns MW, Larsen DK, Cox BJ: Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affective Dis 2000; 60:33–41CrossRefGoogle Scholar
  53. 53.
    Sayer NA, Sackeim HA, Moeller JR, Prudic J, Devanand DP, Coleman EA, Kierksky JE: The relations between observer-rating and self-report of depressive symptomatology. Psychol Assess 1993; 5:350–360CrossRefGoogle Scholar
  54. 54.
    Petkova E, Quitkin FM, McGrath PJ, Stewart JW, Klein DF: A method to quantify rater bias in antidepressant trials. Neuropsychopharmacology 2000; 22:559–65CrossRefPubMedGoogle Scholar
  55. 55.
    Koenig HG, Cohen HJ, Blazer DG, Krishnan KR, Sibert TE: Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993; 41:1169–76CrossRefPubMedGoogle Scholar
  56. 56.
    Kurlowicz LH, Streim JE: Measuring depression in hospitalized, medically ill, older adults. Arch Psychiatr Nurs 1998; 12:209–18CrossRefPubMedGoogle Scholar
  57. 57.
    Linden M, Borchelt M, Barnow S, Geiselmann B: The impact of somatic morbidity on the Hamilton depression rating scale in the very old. Acta Psychiatrica Scandinavica 1995; 92:150–4CrossRefPubMedGoogle Scholar
  58. 58.
    Lyness JM, Cox C, Curry J, Conwell Y, King DA, Caine ED: Older age and the underreporting of depressive symptoms. J Am Geriatr Soc 1995; 43:216–21CrossRefPubMedGoogle Scholar
  59. 59.
    Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, Reynolds CF, 3rd: Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003; 37:99–108CrossRefPubMedGoogle Scholar
  60. 60.
    Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988; 24:709–11PubMedGoogle Scholar
  61. 61.
    Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res 1982; 17:37–49CrossRefGoogle Scholar
  62. 62.
    Burns A, Lawlor B, Craig S: Rating scales in old age psychiatry. Br J Psychiatry 2002; 180:161–7CrossRefPubMedGoogle Scholar
  63. 63.
    Bent-Hansen J, Lunde M, Klysner R, Andersen M, Tanghoj P, Solstad K, Bech P: The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry 2003; 36:313–6CrossRefPubMedGoogle Scholar
  64. 64.
    Wohlreich MM, Mallinckrodt CH, Watkin JG, Hay DP: Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study. BMC Geriatr 2004; 4:11CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161:2050–9CrossRefPubMedGoogle Scholar
  66. 66.
    Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, Mandel FS, Clary CM, Burt T: Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc 2004; 52:86–92CrossRefPubMedGoogle Scholar
  67. 67.
    Poznanski E, Mokros HB, Grossman J, Freeman LN: Diagnostic criteria in childhood depression. Am J Psychiatry 1985; 142:1168–73CrossRefPubMedGoogle Scholar
  68. 68.
    Poznanski EO, Cook SC, Carroll BJ: A depression rating scale for children. Pediatrics 1979; 64:442–50PubMedGoogle Scholar
  69. 69.
    Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the children’s depression rating scale. J Am Acad Child Psychiatry 1984; 23:191–7CrossRefPubMedGoogle Scholar
  70. 70.
    Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54:1031–7CrossRefPubMedGoogle Scholar
  71. 71.
    March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA 2004; 292:807–20CrossRefPubMedGoogle Scholar
  72. 72.
    Kovacs M: The children’s depression, inventory (CDI). Psychopharmacol Bull 1985; 21:995–8PubMedGoogle Scholar
  73. 73.
    Reynolds WM, Graves A: Reliability of children’s reports of depressive symptomatology. J Abnorm Child Psychol 1989; 17:647–55CrossRefPubMedGoogle Scholar
  74. 74.
    Smucker MR, Craighead WE, Craighead LW, Green BJ: Normative and reliability data for the children’s depression inventory. J Abnorm Child Psychol 1986; 14:25–39CrossRefPubMedGoogle Scholar
  75. 75.
    Reynolds WM, Anderson G, Bartell N: Measuring depression in children: a multimethod assessment investigation. J Abnorm Child Psychol 1985; 13:513–26CrossRefPubMedGoogle Scholar
  76. 76.
    Steer RA, Kumar G, Beck JS, Beck AT: Evidence for the construct validities of the Beck Youth Inventories with child psychiatric outpatients. Psychol Rep 2001; 89:559–65CrossRefPubMedGoogle Scholar
  77. 77.
    Brooks SJ, Krulewicz SP, Kutcher S: The Kutcher adolescent depression scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial. J Child Adolesc Psychopharmacol 2003; 13:337–49CrossRefPubMedGoogle Scholar
  78. 78.
    Cheng AT: Case definition and culture: are people all the same? Br J Psychiatry 2001; 179:1–3CrossRefPubMedGoogle Scholar
  79. 79.
    Marsella AJ: Thoughts on cross-cultural studies on the epidemiology of depression. Cult Med Psychiatry 1978; 2:343–57PubMedGoogle Scholar
  80. 80.
    Stompe T, Ortwein-Swoboda G, Chaudhry HR, Friedmann A, Wenzel T, Schanda H: Guilt and depression: a cross-cultural comparative study. Psychopathology 2001; 34:289–98CrossRefPubMedGoogle Scholar
  81. 81.
    Radford MH, Nakane Y, Ohta Y, Mann L, Kalucy RS: Decision making in clinically depressed patients. A transcultural social psychological study. J Nerv Ment Dis 1991; 179:711–9CrossRefPubMedGoogle Scholar
  82. 82.
    Sonawalla SB, Kelly KE, Neault NB, Mischoulon D, Farabaugh AH, Pava JA, Yeung A, Fava M: Predictors of suicidal ideation in a college population., in 154th Annual Meeting of the American Psychiatric Association. New Orleans, LA, 2001Google Scholar
  83. 83.
    Posternak MA, Zimmerman M: Elevated rates of psychosis among treatment-seeking Hispanic patients with major depression. J Nerv Ment Dis 2005; 193:66–9CrossRefPubMedGoogle Scholar
  84. 84.
    Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J: An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341:1329–35CrossRefPubMedGoogle Scholar
  85. 85.
    Marmanidis H, Holme G, Hafner RJ: Depression and somatic symptoms: a cross-cultural study. Aust N Z J Psychiatry 1994; 28:274–8CrossRefPubMedGoogle Scholar
  86. 86.
    Waza K, Graham AV, Zyzanski SJ, Inoue K: Comparison of symptoms in Japanese and American depressed primary care patients. Fam Pract 1999; 16:528–33CrossRefPubMedGoogle Scholar
  87. 87.
    Parker G, Cheah YC, Roy K: Do the Chinese somatize depression? A cross-cultural study. Soc Psychiatry Psychiatr Epidemiol 2001; 36:287–93CrossRefPubMedGoogle Scholar
  88. 88.
    Ulusahin A, Basoglu M, Paykel ES: A cross-cultural comparative study of depressive symptoms in British and Turkish clinical samples. Soc Psychiatry Psychiatric Epidemiol 1994; 29:31–9Google Scholar
  89. 89.
    Fugita SS, Crittenden KS: Towards culture- and population-specific norms for self-reported depressive symptomatology. Int J Soc Psychiatry 1990; 36:83–92CrossRefPubMedGoogle Scholar
  90. 90.
    Lam CY, Pepper CM, Ryabchenko KA: Case identification of mood disorders in Asian American and Caucasian American college students. Psychiatr Q 2004; 75:361–73CrossRefPubMedGoogle Scholar
  91. 91.
    Shumway M, Sentell T, Unick G, Bamberg W: Cognitive complexity of self-administered depression measures. J Affect Disord 2004; 83:191–8CrossRefPubMedGoogle Scholar
  92. 92.
    Moritz S, Meier B, Hand I, Schick M, Jahn H: Dimensional structure of the Hamilton depression rating scale in patients with obsessive-compulsive disorder. Psychiatry Res 2004; 125:171–80CrossRefPubMedGoogle Scholar
  93. 93.
    Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361–70CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Cristina Cusin
    • 1
    Email author
  • Huaiyu Yang
    • 2
  • Albert Yeung
    • 2
  • Maurizio Fava
    • 2
  1. 1.Department of PsychiatryMassachusetts General Hospital and Harvard Medical School, Wang Ambulatory Care Center 812BostonUSA
  2. 2.Department of PsychiatryMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations